KITE
Kite Pharma, Inc.
Director Steven B Ruchefsky sold $1.8M of Kite Pharma, Inc.
Sold$1,789,574
$89.48Price
20,000Shares
−9%Stake
What KITE did after the filing
Prices for KITE after this filing aren't in yet.
Traded Wed, Jun 14. Filed Fri, Jun 16, 1:43 PM ET, during the session. Not investment advice.